Investment Summary

AFINUM Management and Unigestion Invest In Zeit Fur Brot

On August 22, 2018, private equity firms AFINUM Management and Unigestion invested in food company Zeit Fur Brot

Investment Highlights
  • This is AFINUM Management’s 1st and Unigestion’s 1st transaction in the Food sector.
  • This is AFINUM Management’s 25th and Unigestion’s 1st transaction in Germany.

Investment Summary

Date 2018-08-22
Target Zeit Fur Brot
Sector Food
Investor(s) AFINUM Management
Unigestion
Deal Type Growth Capital

Target

Zeit Fur Brot

Berlin, Germany
Zeit Fur Brot is a premium food concept built around bread and related product groups made using high-quality Bioland ingredients. The company currently has six outlets across several German cities. Zeit Für Brot has developed a food proposition that it believes to be unique, based on slow food, quality, artisan craftsmanship, and sustainability. Alongside in-shop sales and takeaway custom, it also delivers its products to organic markets, upscale restaurants, and online platforms such as Amazon Fresh and Amazon PrimeNow. Zeit Fur Brot is based in Berlin, Germany.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

AFINUM Management

Munich, Germany

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 1.1B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

AFINUM Management GmbH is a private equity firm that targets mid-market companies. The Firm primarily targets opportunities in German-speaking Europe and seeks businesses generating €25 to €500 million in revenues. AFINUM will consider a variety of transaction situations, including MBOs, MBIs, and growth capital financings. The Firm will not invest in turnarounds. AFINUM Management GmbH was formed in 2000 and is based Munich. The Firm has additional offices in Zurich and Hong Kong.


DEAL STATS #
Overall 35 of 51
Sector: Food M&A 1 of 1
Type: Growth Capital M&A Deals 11 of 18
Country: Germany M&A 25 of 37
Year: 2018 M&A 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-19 Copytrend

Liebefeld, Switzerland

Copytrend Group is a provider of CAD & graphic plotting as well as reprographic & scanning services. Copytrend Group was founded in 1970 and is based in Liebefeld, Switzerland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-07 Ventomaxx

Landshut, Germany

Ventomaxx is a provider of mainly decentral ventilation systems with state-of-the-art technology and highest architectural standards. The modular design as well as the flexible application possibilities make Ventomaxx a preferred partner for architects and building engineers, especially for larger projects requiring individual concepts. Ventomaxx was founded in 1996 and is based in Landshut, Germany.

Buy -
Investor

Unigestion

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1971
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Unigestion is an asset manager with a private equity division focused on global mid-market companies across Europe, North America, and Asia. Unigestion considers direct investments in established companies, secondary position acquisitions, and investments in emerging fund managers. The Firm invests in a variety of industries including industrials, agriculture, distribution, logistics, utilities, software, education, nutrition, leisure, and healthcare. Unigestion was founded in 1971 and is based in Geneva, Switzerland.


DEAL STATS #
Overall 2 of 13
Sector: Food M&A 1 of 1
Type: Growth Capital M&A Deals 2 of 3
Country: Germany M&A 1 of 2
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-08 Evaluate

London, United Kingdom

Evaluate is a provider of commercial intelligence to the global life sciences industry. Evaluate is the trusted provider of mission critical commercial information for complex business decisions to the pharmaceutical industry. Evaluate’s core product is an industry leading set of analyst consensus forecasts that provides detailed insights at the product, disease, indication and geographic level. Evaluate creates value by structuring, normalising and integrating data from company filings, research organisations, and government bodies and providing tools that drive analytical insights from data. Evaluate was the first mover in this particular space and is a leading provider today. Evaluate was founded in 1996 and is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-13 HealthTech BioActives

Barcelona, Spain

HealthTech BioActives is a manufacturer of active pharmaceutical ingredients (APIs), excipients, flavorings and sweeteners for the pharmaceutical, nutraceutical and cosmetic industries, as well as ingredients for human and animal feed. HealthTech BioActives was founded in 1978 and is based in Barcelona, Spain.

Buy -